NCT01713166View on ClinicalTrials.gov

Effects of Colloid and Crystalloid on the Microcirculatory Alterations During Off-pump Coronary Artery Bypass Surgery

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions
Cardiac Surgery
Interventions
DRUG

plasmalyte solution

plasmalyte solution

DRUG

Hextend

Hetastarch administration instead of crystalloids until the total amount given reached 20 ml/kg, which is the maximally allowed daily dose. Afterward, plasmalyte solution infusion to meet the fluid requirements.

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER

NCT01713166 - Effects of Colloid and Crystalloid on the Microcirculatory Alterations During Off-pump Coronary Artery Bypass Surgery | Biotech Hunter | Biotech Hunter